Find Grants for Native American & Tribal Governments

Find Out If You Qualify for Verified Grants! Discover your eligibility and access 1,903 verified grants for nonprofits, small businesses, startups, and individuals from trusted foundations and government sources.

Total Dollar Available
$ 100 Trillion

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

Deadline: October 19, 2026


Opportunity Number: PAR-25-155

Agency: National Institutes of Health

Open Date: December 11, 2024

Close Date: October 19, 2026

Status: Posted

CFDA Numbers: 93.350

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)

Deadline: June 18, 2026


Opportunity Number: PAR-25-157

Agency: National Institutes of Health

Open Date: December 10, 2024

Close Date: June 18, 2026

Status: Posted

CFDA Numbers: 93.350

Chemical Evolution of the Solid Earth and Volcanology

No deadline specified


Opportunity Number: 25-516

Agency: U.S. National Science Foundation

Open Date: December 10, 2024

Status: Posted

CFDA Numbers: 47.050

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-321

Agency: National Institutes of Health

Open Date: December 10, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.394, 93.395, 93.393, 93.399, 93.396

BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)

Deadline: June 15, 2026


Opportunity Number: RFA-EY-25-001

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: June 15, 2026

Status: Posted

CFDA Numbers: 93.173, 93.286, 93.213, 93.865, 93.866, 93.853, 93.867, 93.273, 93.242, 93.279

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Deadline: November 2, 2026


Opportunity Number: PAR-24-280

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: November 2, 2026

Status: Posted

CFDA Numbers: 93.846

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

Deadline: November 2, 2026


Opportunity Number: PAR-24-279

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: November 2, 2026

Status: Posted

CFDA Numbers: 93.846

HARMONY: Human-Centric Analytics for Resilient & Modernized Power sYstems

Deadline: April 9, 2026


Opportunity Number: DE-FOA-0003446

Agency: National Energy Technology Laboratory

Open Date: December 9, 2024

Close Date: April 9, 2026

Status: Posted

CFDA Numbers: 81.122

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Deadline: March 4, 2027


Opportunity Number: PAR-25-141

Agency: National Institutes of Health

Open Date: December 9, 2024

Close Date: March 4, 2027

Status: Posted

CFDA Numbers: 93.846

Life and Environments Through Time

No deadline specified


Opportunity Number: 25-517

Agency: U.S. National Science Foundation

Open Date: December 7, 2024

Status: Posted

CFDA Numbers: 47.050

Structure and Physics of the Solid Earth

No deadline specified


Opportunity Number: 25-518

Agency: U.S. National Science Foundation

Open Date: December 7, 2024

Status: Posted

CFDA Numbers: 47.050

Water, Landscape, and Critical Zone Processes

No deadline specified


Opportunity Number: 25-519

Agency: U.S. National Science Foundation

Open Date: December 7, 2024

Status: Posted

CFDA Numbers: 47.050

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)

Deadline: September 7, 2027


Opportunity Number: PAR-24-330

Agency: National Institutes of Health

Open Date: December 6, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Deadline: May 7, 2027


Opportunity Number: PAR-25-100

Agency: National Institutes of Health

Open Date: December 6, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.279

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Deadline: June 2, 2026


Opportunity Number: RFA-TR-25-002

Agency: National Institutes of Health

Open Date: December 6, 2024

Close Date: June 2, 2026

Status: Posted

CFDA Numbers: 93.350

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-298

Agency: National Institutes of Health

Open Date: December 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.839, 93.173, 93.279, 93.840, 93.273, 93.395, 93.855, 93.865, 93.233, 93.853, 93.361, 93.121, 93.393, 93.172, 93.399, 93.866, 93.846, 93.837, 93.838, 93.396, 93.351, 93.394, 93.242, 93.213, 93.867, 93.113, 93.286

Security, Privacy, and Trust in Cyberspace

Deadline: September 28, 2026


Opportunity Number: 25-515

Agency: U.S. National Science Foundation

Open Date: December 6, 2024

Close Date: September 28, 2026

Status: Posted

CFDA Numbers: 47.075, 47.076, 47.049, 47.070

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Deadline: December 3, 2027


Opportunity Number: RFA-DA-26-055

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: December 3, 2027

Status: Posted

CFDA Numbers: 93.273, 93.279

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Deadline: December 3, 2027


Opportunity Number: RFA-DA-26-056

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: December 3, 2027

Status: Posted

CFDA Numbers: 93.273, 93.279

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-299

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.273, 93.307, 93.399

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-025

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.838, 93.839, 93.233, 93.837

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-026

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-239

Agency: National Institutes of Health

Open Date: December 5, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Deadline: November 5, 2027


Opportunity Number: PAR-25-297

Agency: National Institutes of Health

Open Date: December 4, 2024

Close Date: November 5, 2027

Status: Posted

CFDA Numbers: 93.866

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)

Deadline: March 20, 2026


Opportunity Number: PAR-25-242

Agency: National Institutes of Health

Open Date: December 4, 2024

Close Date: March 20, 2026

Status: Posted

CFDA Numbers: 93.313, 93.173, 93.865, 93.989, 93.242, 93.399, 93.853, 93.286, 93.867